Differentstrategies have been developed for MYC inhibition, such asadenovirus expressing antisense c-MYC (Chen et al., 2001; Xie etal., 2009) or shRNA anti-MYC (Li Y et al., 2013) leading to tumor inhibition invivo and in vitro (Table S1). The gene discussed is MYC; the disease is neoplasm.